Company
Warby Parker, Inc.
Headquarters: New York, NY, United States
Employees: 1,681
CEO: Mr. Neil Harris Blumenthal
Warby Parker, Inc. Categories
United States Healthcare Medical Instruments & SuppliesUnited States Healthcare United States Medical Instruments & Supplies
Top Competitors by Market Capitalization
Industry: Medical Instruments & Supplies
| Company | Market Cap (USD) |
|---|---|
| Intuitive | $216.79 B |
| EssilorLuxottica SA | $116.96 B |
| Becton, Dickinson and Company | $69.74 B |
| HOYA Corp | $45.26 B |
| Alcon Inc. | $41.55 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Warby Parker Inc. designs, manufactures, and retails eyewear products for men and women. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as eye exams and vision tests. As of June 30, 2021, it operated 145 retail stores, which included 142 locations in the United States and 3 locations in Canada, as well as online stores. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Financials
| Last Financial Reports Date | Dec. 31, 2023 |
| Revenue TTM | $669.8 M |
| EBITDA | $-30,212,000 |
| Gross Profit TTM | $365.2 M |
| Profit Margin | -9.44% |
| Operating Margin | -11.33% |
| Quarterly Revenue Growth | 10.50% |
Stocks & Indices
Warby Parker, Inc. has the following listings and related stock indices.
Stock: NYSE: WRBY wb_incandescent